Short interest for My Size gives investors a sense of the degree to which investors are betting on the decline of My Size's stock. Short interest data is updated every two weeks.

My Size Stock (NASDAQ:MYSZ), Short Interest Report

My Size

My Size Inc is a USA based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers, and licensing cloud-enabled software subscriptions, associated software maintenance and support.

Earnings

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Trading Ideas

MITK

MYSZ

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday

Price Target

Analyst Ratings

CRWD

GDDY

KEYS

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

CrowdStrike To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Tuesday

Intraday Update

Movers

ACLS

AEHR

ALGN

ALZN

AMTX

APTO

BGNE

BHAT

BKYI

BTTX

CHRS

COMM

ENSC

FRBN

HTCR

IBRX

KERN

LITE

LMDX

LUNR

MGTX

MIRO

MOTS

NVVE

NXPI

RVTY

SEEL

SHOT

SVFD

TENX

VYNE

YGMZ

Gainers


	Miromatrix Medical Inc.  (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash.


Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

My Size Inc

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments">high dividend payout</a>. 
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the industrials sector.
<h3 class="wp-block-heading">Genco Shipping &amp; Trading Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNK#NYSE">GNK</a>)</h3>
<ul>
<li>Dividend Yield: 4.95%</li>
<li>Jefferies analyst Omar Nokta maintained a Buy rating and increased the price target from $26 to $27 on May 9. This analyst has an accuracy rate of 80%.</li>
<li>Stifel analyst Benjamin Nolan maintained a Buy rating and raised the price target from $22 to $23 on April 19. This analyst has an accuracy rate of 75%.</li>
<li>Recent News: On May 8, Genco Shipping &amp; Trading posted downbeat quarterly earnings.</li>
</ul>
<h3 class="wp-block-heading">Star Bulk Carriers Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBLK#NASDAQ">SBLK</a>)</h3>
<ul>
<li>Dividend Yield: 5.53%</li>
<li>Stifel analyst Benjamin Nolanmaintained a Buy rating and raised the price target from $76 to $83 on Feb. 14. This analyst has an accuracy rate of 75%.</li>
<li>Jefferies analyst Omar Noktamaintained a Buy rating and boosted the price target from $22 to $24 on Nov. 30, 2023. This analyst has an accuracy rate of 80%.</li>
<li>Recent News: On April 9, Star Bulk completed merger with Eagle Bulk.</li>
</ul>
<h3 class="wp-block-heading">Trinity Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRN#NYSE">TRN</a>)</h3>
<ul>
<li>Dividend Yield: 3.59%</li>
<li>TD Cowen analyst Matt Elkott maintained a Buy rating and raised the price target from $30 to $33 on May 2. This analyst has an accuracy rate of 74%.</li>
<li>Wells Fargo analyst Allison Poliniak maintained an Overweight rating and raised the price target from $27 to $31 on Aug. 2, 2023. This analyst has an accuracy rate of 68%.</li>
<li>Recent News: On May 1, Trinity Industries reported better-than-expected first-quarter financial results.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/24/05/38759538/how-to-earn-500-a-month-from-home-depot-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Home Depot Stock Ahead Of Q1 Earnings</a>

Long Ideas

Dividends

SBLK

These 3 Industrials Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts

HSBC analyst Achal Kumar initiates coverage on American Airlines Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) with a Buy rating and announces Price Target of $17.9.

Initiation

HSBC Initiates Coverage On American Airlines Gr with Buy Rating, Announces Price Target of $17.9

Biotech

Guidance

Health Care

General

VRCA

As Of March 31, 2024, Verrica Pharmaceuticals Had Cash And Cash Equivalents Of $48.9M Expected To Provide Cash Runway Into The First Quarter Of 2025

WIIM

INKT

MiNK Therapeutics shares are trading higher after the company announced plans to sell securities in a private placement financing for $5.8 million. The financing is earmarked for accelerating its MiNK-215 clinical trials.

Akoustis Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTS#NASDAQ">AKTS</a>) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.12) by 16.67 percent. The company reported quarterly sales of $7.510 million which missed the analyst consensus estimate of $8.553 million by 12.19 percent. This is a 2.09 percent increase over sales of $7.356 million the same period last year.

Earnings Misses

AKTS

Akoustis Technologies Q3 2024 Adj EPS $(0.14) Misses $(0.12) Estimate

HSBC analyst Achal Kumar initiates coverage on United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) with a Buy rating and announces Price Target of $69.2.

HSBC Initiates Coverage On United Airlines Holdings with Buy Rating, Announces Price Target of $69.2

Verrica Pharmaceuticals Q1 2024 GAAP EPS $(0.44) Misses $(0.42) Estimate, Sales $3.826M Beat $2.777M Estimate

FULC

Fulcrum Therapeutics shares are trading higher after the company reported better-than-expected Q1 GAAP EPS results.

MiNK Therapeutics To Sell Securities In Private Placement Financing For $5.8M; Financing Earmarked For Accelerating MiNK-215 Clinical Trials

A U.S. auto safety regulator has commenced an investigation into Amazon.com&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) automated Zoox vehicles, owing to concerns about its sudden braking leading to collisions. 
What Happened:&nbsp;The&nbsp;National Highway Traffic Safety Administration&nbsp;(NHTSA) said that it was aware of two incidents involving Zoox vehicles. In both cases, the vehicles, equipped with Zoox&#8217;s Automated Driving System (ADS), are said to have braked abruptly and without warning, leading to rear-end collisions. Both incidents, which occurred during daylight hours, involved a Toyota Highlander and resulted in minor injuries to the motorcyclists who collided with the Zoox vehicles.
The regulator has verified that the Zoox vehicles were in autonomous mode during the incidents. The preliminary evaluation of about 500 Zoox vehicles will scrutinize the performance of the Zoox ADS, especially in relation to the reported collisions. It will also assess the system&#8217;s behavior in crosswalks around vulnerable road users and in other similar rear-end collision scenarios, the regulator said. 
Why It Matters: Amazon acquired Zoox for $1.3 billion in 2020. In March, Zoox <a href="https://www.benzinga.com/news/24/03/37737933/amazons-zoox-expands-robotaxi-testing-goals-in-las-vegas-after-waymo-starts-giving-public-driverless">announced advancements </a>to its robotaxi testing in Las Vegas and California, including increasing the cap on top speed to 45 mph from 35 mph, while also expanding the area in Las Vegas where these robotaxis can travel to about 5 miles from its Las Vegas headquarters to the south end of the Strip along multiple routes. 
&nbsp;Zoox is eyeing providing its first rides to the public later this year.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="http://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:&nbsp;<a href="https://www.benzinga.com/news/24/05/38782522/spacex-starship-likely-to-fly-for-4th-time-next-month-as-elon-musk-reaffirms-new-goals" target="_blank" rel="noreferrer noopener">SpaceX Starship Likely To Fly For 4th Time Next Month As Elon Musk Reaffirms New Goals</a>
Photo via Shutterstock

AMZN

NHTSA Opens Probe Into Amazon's 500 Zoox Vehicles Over Sudden Braking Concerns

HSBC analyst Achal Kumar initiates coverage on Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) with a Buy rating and announces Price Target of $72.8.

HSBC Initiates Coverage On Delta Air Lines with Buy Rating, Announces Price Target of $72.8

ZEEKR Intelligent Technology Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZK#NYSE">ZK</a>) shares rose <a href="https://www.benzinga.com/premarket">in premarket trading</a> on Monday, signaling that the Chinese electric vehicle manufacturer could add to gains from Friday&#8217;s splendid market debut.
Geely Automobile Holdings Limited (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GELYF#OTC">GELYF</a>)-backed Zeekr, a manufacturer of premium EVs, had a <a href="https://www.benzinga.com/markets/equities/24/05/38774344/chinese-tesla-rival-zeekr-soars-35-on-nyse-debut-valuation-hits-6-8b">strong debut on NYSE on Friday.</a> Through an initial public offering, the company offered 21,000,000 ADRs, each representing 10 ordinary shares, at $21 per ADS, the higher end of the estimated range.
As of Friday&#8217;s close, the company&#8217;s valuation was at $64.03 billion. 
After opening the debut session at $26 per ADS, the stock moved in a range of $25.52-$29.36 before ending up 34.57% at $28.26, according to<a href="https://benzinga.grsm.io/lxquj26b2sag"> Benzinga Pro data.</a>
In premarket, the stock rose an incremental 3.86% to $29.35.
&nbsp;Incorporated in&nbsp;March 2021, Zeekr now sells
<ul>
<li>ZEEKR 001, a five-seater, cross-over hatchback</li>
<li>ZEEKR 001 FR, the latest cross-over hatchback</li>
<li>ZEEKR 009, a luxury six-seater MPV,</li>
<li>ZEEKR X, a compact SUV</li>
<li> upscale sedan model</li>
</ul>
In the Form F-1 filing, Zeekr said it intends to use the net proceeds to develop more advanced BEV technologies, expand selling and marketing, as well as its service and charging network, and meet general corporate purposes.
Zeekr&#8217;s U.S. stock market debut comes at a time when the Biden administration is planning to increase tariffs on Chinese EV imports.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="http://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
See Also:<a href="https://www.benzinga.com/money/best-electric-vehicle-stocks"> Best EV Stocks</a>
Photo via Shutterstock

Asia

Equities

GELYF

Geely-Backed Chinese EV Startup Zeekr's Stock Looks To Extend Gains After Strong New York Market Debut

The Company is canceling its previously announced earnings release and call scheduled for before U.S. market open on May&nbsp;14, 2024. The Company expects to file the Q1 2024 10-Q as soon as practicable and no later
The Company is canceling its previously announced earnings release and call scheduled for before U.S. market open on May&nbsp;14, 2024. The Company expects to file the Q1 2024 10-Q as soon as practicable and no later than the May&nbsp;20, 2024

AUTL

Autolus Therapeutics Delays Its First Quarter 2024 Earnings Release and Conference Call

Sweetgreen shares are trading higher on continued strength after the company last week reported better-than-expected Q1 sales results.

BILI

CORRECTION: Sweetgreen Ticker Is 'SG'

TD Cowen analyst Dan Brennan initiates coverage on Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) with a Buy rating and announces Price Target of $2.8.

BDSX

TD Cowen Initiates Coverage On Biodesix with Buy Rating, Announces Price Target of $2.8

Baird analyst Andrew Wittmann maintains Construction Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROAD#NASDAQ">ROAD</a>) with a Neutral and raises the price target from $50 to $60.

ROAD

Baird Maintains Neutral on Construction Partners, Raises Price Target to $60

CLSK

MARA

RIOT

Shares of crypto-related stocks are trading higher amid a rise in Bitcoin.

RBC Capital analyst Brian Abrahams initiates coverage on Corbus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) with a Outperform rating and announces Price Target of $77.

CRBP

RBC Capital Initiates Coverage On Corbus Pharmaceuticals with Outperform Rating, Announces Price Target of $77

Seritage Growth Properties shares are trading lower. The company reported Q1 financial results.

My Size Inc (MYSZ) has released an update. My Size, Inc. has granted significant restricted share awards to three of its top executives as part of ...

My Size Inc Awards Shares to Top Executives for Retention

Warning: MYSZ is at high risk of performing badly

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
My Size (NASDAQ:<a href="https://investorplace.com/stock-quotes/mysz-stock-quote/">MYSZ</a>) just reported results for the fourth quarter of 2023.<ul><li>My Size reported earnings per share of -31 cents. This was below the analyst estimate for EPS of -12 cents.</li><li>The company reported revenue of $2.83 million.</li><li>This was 19.14% worse than the analyst estimate for revenue of $3.50 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/mysz-stock-earnings-my-size-for-q4-of-2023/">MYSZ Stock Earnings: My Size Misses EPS, Misses Revenue for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MYSZ Stock Earnings: My Size Misses EPS, Misses Revenue for Q4 2023

MySize announces reverse stock split to regain Nasdaq compliance

My Size announces reverse stock split to regain Nasdaq compliance

Catalyst Watch: Tesla, Boeing and General Motors brace for earnings fireworks

PI, IZM among major tech gainers; BNAI, CETX among losers

MySize regains compliance with Nasdaq minimum closing bid price rule

My Size Inc (MYSZ) has provided an update. My Size, Inc. has successfully regained compliance with Nasdaq's minimum closing bid price requirement, ...

My Size Inc Regains Nasdaq Compliance, Resolves Deficiency Issue

ABBV

ALPN

ANSNF

AQMS

AUID

AUST

BMWYY

BNAI

BYDDF

BYND

CART

CETX

CMCSA

CPNG

CPRI

FFIE

GOOG

INTC

JBLU

MBGAF

MCBC

MSFT

NISTF

NVDA

PERI

RBRK

RILY

RKLB

SMMT

SNAP

SNBR

TSLA

URBN

VLKAF

VSTE

MySize's (MYSZ) Naiz Fit Smart Catalogue: Pioneering AI-Driven Sizing Solutions for the Jeans Sector

Press Releases

MySize's Naiz Fit Wins Innovation Award at Paris Retail Week 2023 for its Apparel Sizing Solutions

MySize Reports Third Quarter 2023 Financial Results: Record Nine-Month Revenues and Gross Profits

My size inc (MYSZ) emerging ai-driven measurement solutions company receives bullish target from wall street analyst

Entertainment

Fox Business Network TV show, Varney and Company Interviews MySize CEO Ronen Luzon

MySize to Exhibit at National Retail Federation 2024 in New York City

Naiz Fit, a My Size Inc Company, Unveils Groundbreaking Generative AI Strategies to Revolutionize Fashion Tech

-

-

-

-

-

-

-

-

-

-

-

-

-

-

My Size Stock (NASDAQ:MYSZ), Short Interest Report

People Also Watch